Where Short-chain fatty acids (SCFAs) is reported
Also listed as: Butyrate, propionate, acetate
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Long COVID | ↕ inconsistent | healthy controls | GI and metabolic symptoms | Baalbaki et al. 2025 |
Frequently asked questions
In which conditions is Short-chain fatty acids (SCFAs) altered?
In the OSMF atlas Short-chain fatty acids (SCFAs) is reported in Long COVID. It is mixed in 1 across 1 entries.
Is there a standard clinical test for Short-chain fatty acids (SCFAs)?
The atlas entries for Short-chain fatty acids (SCFAs) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Short-chain fatty acids (SCFAs) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.